Position
Entropy Technologies, LP in Acadia Pharmaceuticals Inc
Back to the book · All holders of ACAD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$56.9K$26.71 → $22.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.8K | $341.8K | — | — | — | 0.0% |
| Q1 2026 | 24.1K | $535.6K | $22.26 | −$56.9K | $250.7K | 0.0% |